Renal outcome in multiple myeloma patients with cast nephropathy: a retrospective analysis of potential predictive values on clinical and renal outcome.
Lina Z RüsingNicolas KozakowskiGeorg JeryczynskiLea VospernikJulia RiedlThomas ReiterHeinz GisslingerHermine AgisMaria-Theresa KrauthPublished in: Hematology (Amsterdam, Netherlands) (2024)
In summary, our data suggests, that a rapid start with systemic hematologic treatment in patients with MM and CN is crucial and achieving an early hematologic response is important for renal recovery. Moreover, achieving a deep hematologic response and subsequent renal recovery improves clinical outcome as reflected by an overall survival benefit.